Kathren L. Fink - Publications

Affiliations: 
Yale University, New Haven, CT 

4/25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Fink KL, López-Giráldez F, Kim IJ, Strittmatter SM, Cafferty WB. Identification of Intrinsic Axon Growth Modulators for Intact CNS Neurons after Injury. Cell Reports. 18: 2687-2701. PMID 28297672 DOI: 10.1016/J.Celrep.2017.02.058  0.96
2016 Fink KL, Cafferty WB. Reorganization of Intact Descending Motor Circuits to Replace Lost Connections After Injury. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 26846379 DOI: 10.1007/S13311-016-0422-X  1
2015 Fink KL, Strittmatter SM, Cafferty WB. Comprehensive Corticospinal Labeling with mu-crystallin Transgene Reveals Axon Regeneration after Spinal Cord Trauma in ngr1-/- Mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 15403-18. PMID 26586827 DOI: 10.1523/Jneurosci.3165-15.2015  1
2015 Siegel CS, Fink KL, Strittmatter SM, Cafferty WB. Plasticity of intact rubral projections mediates spontaneous recovery of function after corticospinal tract injury. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 1443-57. PMID 25632122 DOI: 10.1523/Jneurosci.3713-14.2015  1
Low-probability matches
2015 Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink KL, Barnett GH, Zhu JJ, Henson JW, Engelhard HH, Chen TC, et al. Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial. Jama. 314: 2535-43. PMID 26670971 DOI: 10.1001/Jama.2015.16669  0.01
2015 Nabors LB, Fink KL, Mikkelsen T, Grujicic D, Tarnawski R, Nam do H, Mazurkiewicz M, Salacz M, Ashby L, Zagonel V, Depenni R, Perry JR, Hicking C, Picard M, Hegi ME, et al. Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study. Neuro-Oncology. 17: 708-17. PMID 25762461 DOI: 10.1093/neuonc/nou356  0.01
2014 Cairncross JG, Wang M, Jenkins RB, Shaw EG, Giannini C, Brachman DG, Buckner JC, Fink KL, Souhami L, Laperriere NJ, Huse JT, Mehta MP, Curran WJ. Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 783-90. PMID 24516018 DOI: 10.1200/Jco.2013.49.3726  0.01
2011 Yuan K, Fink KL, Winer JA, Schreiner CE. Local connection patterns of parvalbumin-positive inhibitory interneurons in rat primary auditory cortex. Hearing Research. 274: 121-8. PMID 20600741 DOI: 10.1016/J.Heares.2010.06.014  0.01
2008 Reardon DA, Fink KL, Mikkelsen T, Cloughesy TF, O'Neill A, Plotkin S, Glantz M, Ravin P, Raizer JJ, Rich KM, Schiff D, Shapiro WR, Burdette-Radoux S, Dropcho EJ, Wittemer SM, et al. Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 5610-7. PMID 18981465 DOI: 10.1200/JCO.2008.16.7510  0.01
2008 Lamborn KR, Yung WK, Chang SM, Wen PY, Cloughesy TF, DeAngelis LM, Robins HI, Lieberman FS, Fine HA, Fink KL, Junck L, Abrey L, Gilbert MR, Mehta M, Kuhn JG, et al. Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas. Neuro-Oncology. 10: 162-70. PMID 18356283 DOI: 10.1215/15228517-2007-062  0.01
2007 Kuhn JG, Chang SM, Wen PY, Cloughesy TF, Greenberg H, Schiff D, Conrad C, Fink KL, Robins HI, Mehta M, DeAngelis L, Raizer J, Hess K, Lamborn KR, Dancey J, et al. Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 7401-6. PMID 18094423 DOI: 10.1158/1078-0432.CCR-07-0781  0.01
2007 Loghin ME, Prados MD, Wen P, Junck L, Lieberman F, Fine H, Fink KL, Metha M, Kuhn J, Lamborn K, Chang SM, Cloughesy T, DeAngelis LM, Robins IH, Aldape KD, et al. Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 7133-8. PMID 18056194 DOI: 10.1158/1078-0432.Ccr-07-0874  0.01
2006 Cloughesy TF, Wen PY, Robins HI, Chang SM, Groves MD, Fink KL, Junck L, Schiff D, Abrey L, Gilbert MR, Lieberman F, Kuhn J, DeAngelis LM, Mehta M, Raizer JJ, et al. Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 3651-6. PMID 16877733 DOI: 10.1200/Jco.2006.06.2323  0.01
2006 Fink KL. Chemotherapy and anti-epileptic drug interactions Handbook of Brain Tumor Chemotherapy. 44-57. DOI: 10.1016/B978-012088410-0/50041-X  0.01
2004 Chang SM, Prados MD, Yung WK, Fine H, Junck L, Greenberg H, Robins HI, Mehta M, Fink KL, Jaeckle KA, Kuhn J, Hess K, Schold C. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial. Cancer. 100: 1712-6. PMID 15073861 DOI: 10.1002/Cncr.20157  0.01
2004 Prados MD, Yung WK, Jaeckle KA, Robins HI, Mehta MP, Fine HA, Wen PY, Cloughesy TF, Chang SM, Nicholas MK, Schiff D, Greenberg HS, Junck L, Fink KL, Hess KR, et al. Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. Neuro-Oncology. 6: 44-54. PMID 14769140 DOI: 10.1215/S1152851703000292  0.01
2004 Prados MD, Yung WK, Fine HA, Greenberg HS, Junck L, Chang SM, Nicholas MK, Robins HI, Mehta MP, Fink KL, Jaeckle KA, Kuhn J, Hess KR, Schold SC. Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study. Neuro-Oncology. 6: 33-7. PMID 14769138 DOI: 10.1215/S1152851703000309  0.01
2004 Schold SC, Kokkinakis DM, Chang SM, Berger MS, Hess KR, Schiff D, Robins HI, Mehta MP, Fink KL, Davis RL, Prados MD. O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas. Neuro-Oncology. 6: 28-32. PMID 14769137 DOI: 10.1215/S115285170300019X  0.01
2000 Schold SC, Kuhn JG, Chang SM, Bosik ME, Robins HI, Mehta MP, Spence AM, Fulton D, Fink KL, Prados MD. A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: a North American Brain Tumor Consortium study. Neuro-Oncology. 2: 34-9. PMID 11302252  0.01
1997 Rosenthal DI, Okani O, Sinard RJ, Truelson JM, Fink KL, Kamen B, Vuitch FM, Griener J, Orr KY, McWhorter J, Carbone DP. Concurrent intensive radiotherapy and prolonged continuous-infusion paclitaxel for locally advanced solid tumors: Results of three phase I trials Seminars in Radiation Oncology. 7: S1-42-S1-46.  0.01
1996 Fink KL, Rushing EJ, Schold SC, Nisen PD. Infrequency of p53 gene mutations in ependymomas. Journal of Neuro-Oncology. 27: 111-5. PMID 8699232  0.01
1988 Fink KL, Wieben ED, Woloschak GE, Spelsberg TC. Rapid regulation of c-myc protooncogene expression by progesterone in the avian oviduct. Proceedings of the National Academy of Sciences of the United States of America. 85: 1796-800. PMID 3162308 DOI: 10.1073/Pnas.85.6.1796  0.01
1985 Kravitz SR, Fink KL, Huber S, Bohanske L, Cicilioni S. Osseous changes in the second ray of classical ballet dancers. Journal of the American Podiatric Medical Association. 75: 346-8. PMID 4009473 DOI: 10.7547/87507315-75-7-346  0.01
1985 Kravitz SR, Huber S, Murgia CJ, Fink KL, Shaffer M, Varela L. Biomechanical study of bunion deformity and stress produced in classical ballet. Journal of the American Podiatric Medical Association. 75: 338-45. PMID 4009472 DOI: 10.7547/87507315-75-7-338  0.01
1984 Fink KL, Gross RW. Modulation of canine myocardial sarcolemmal membrane fluidity by amphiphilic compounds. Circulation Research. 55: 585-94. PMID 6091941  0.01
Hide low-probability matches.